| 2024-11-19 | -0.35 % |
|
| 2024-11-15 | -4.35 % |
|
| 2024-11-08 | +3.01 % |
|
| 2024-11-07 | -0.81 % |
|
| 2024-11-04 | +1.83 % |
|
| 2024-11-01 | -0.1 % |
|
| 2024-10-31 | -1.39 % |
|
| 2024-10-30 | -0.06 % |
|
| 2024-10-29 | +9.5 % |
|
| 2024-10-28 | +0.6 % |
|
| 2024-10-24 | +0.29 % |
|
| 2024-10-23 | +0.45 % |
|
| 2024-10-17 | +0.17 % |
|
| 2024-10-15 | -0.55 % |
|
| 2024-10-14 | +0.86 % |
- Leidos Holdings, Inc. (LDOS) experienced a 0.86% increase in stock value, despite Wedge Capital Management L L P NC reducing its stake by 20.7% in the third quarter, indicating potential positive market sentiment or external factors driving the stock up.
- Leidos Holdings, Inc. (NYSE:LDOS) saw a 0.86% increase in stock value due to a consensus rating of "Moderate Buy" from multiple analysts, with several raising their price targets significantly, reflecting positive growth expectations and recent strong earnings results.
- Leidos Holdings, Inc. (NYSE: LDOS) shares reached a new 52-week high of $168.18, closing at $168.03, up 0.86%, likely due to positive analyst ratings and market sentiment.
|
| 2024-10-11 | +1.61 % |
|
| 2024-10-10 | -1.86 % |
- Leidos Holdings, Inc. (LDOS) stock experienced a decline of 1.86%, despite Artemis Investment Management LLP significantly increasing its position in the company by 66.9% during the third quarter, which may suggest underlying market concerns or investor sentiment affecting the stock's performance.
The decline in Leidos (LDOS) stock could be attributed to broader market trends, investor sentiment, or specific concerns related to the company's outlook or the aerospace industry rather than the increase in institutional ownership.
- Leidos (LDOS) stock decreased by 1.86% despite analysts at Citigroup raising their price target from $169.00 to $194.00 and maintaining a "buy" rating, potentially due to market reactions or investor sentiment not fully aligning with the positive outlook.
- Leidos (LDOS) stock fell by 1.86% due to a combination of emerging investor activities, market conditions, and recent trading activities by insiders, including both purchases and sales of shares, reflecting mixed sentiment among stakeholders.
|
| 2024-10-08 | -0.02 % |
|
| 2024-10-07 | +0.16 % |
|
| 2024-10-02 | +0.12 % |
|
| 2024-10-01 | +1.23 % |
|
| 2024-09-30 | +2.05 % |
|
| 2024-09-27 | +0.81 % |
|
| 2024-09-26 | +0.27 % |
|
| 2024-09-25 | -0.28 % |
|
| 2024-09-24 | -0.77 % |
|
| 2024-09-23 | +1.67 % |
|
| 2024-09-18 | -0.36 % |
|
| 2024-09-16 | -0.44 % |
|
| 2024-09-13 | +0.92 % |
|
| 2024-09-10 | +0.39 % |
|
| 2024-09-06 | -1.89 % |
|
| 2024-09-05 | -0.19 % |
|
| 2024-09-03 | -1.71 % |
|
| 2024-08-15 | +0.41 % |
|
| 2024-08-12 | +0.33 % |
|
| 2024-08-01 | +0.24 % |
|
| 2024-07-31 | -1.08 % |
|
| 2024-07-24 | -3.12 % |
|
| 2024-07-23 | +1.27 % |
|
| 2024-07-17 | -1.03 % |
|
| 2024-07-16 | +1.91 % |
|
| 2024-07-12 | +0.65 % |
- Summary: Geneos Wealth Management Inc. increased its holdings in Leidos Holdings, Inc. by 15.7% during the first quarter, with other large investors also adding positions, leading to a 0.65% increase in Leidos stock price last night.
Reason for Leidos (LDOS) stock increase: The increase in Leidos stock was likely influenced by the higher stakes taken by institutional investors like Geneos Wealth Management Inc., Franklin Resources Inc., International Assets Investment Management LLC, Raymond James & Associates, Leeward Investments LLC MA, and CHURCHILL MANAGEMENT Corp, indicating growing confidence in the company's performance and potential. Additionally, the positive quarterly earnings report and strong revenue growth of Leidos contributed to the stock's upward trend.
|
| 2024-07-11 | +0.07 % |
|
| 2024-07-05 | -0.77 % |
|
| 2024-07-03 | +0.53 % |
- The article discusses Leidos Holdings, Inc. (LDOS) stock, which was up by 0.53% last night, and highlights how various institutional investors, including Wealth Enhancement Advisory Services LLC, have increased their positions in the company, impacting its stock price positively. The stock's upward movement is likely influenced by the increased stake from these investors and positive analyst ratings, with a reported average target price of $146.08.
- The article reports that Leidos Holdings, Inc. (NYSE: LDOS) stock was up 0.53% as State of Michigan Retirement System increased its stake, with institutional investors like Farmers & Merchants Trust Co and Lindbrook Capital LLC also investing, leading to positive ratings and target price increases from equity analysts, and followed by an increase in quarterly earnings, including revenue exceeding estimates and strong EPS, resulting in a recent dividend declaration, with the stock currently having a "Moderate Buy" rating and an average target price of $146.08.
|
| 2024-07-02 | +0.21 % |
- The article discusses Oak Thistle LLC's new position in Leidos Holdings, Inc. stock, where they bought 3,044 shares, leading to a slight increase of 0.21% in the stock price, with various large institutional investors also adjusting their holdings of LDOS; the stock went up likely due to positive earnings results, beating estimates with strong revenue and outlook projections.
- The article discusses Chapin Davis Inc. acquiring a new stake in Leidos Holdings, Inc. (NYSE:LDOS) during the 1st quarter, along with other hedge funds recently buying and selling shares of the company, which has led to a 0.21% increase in LDOS stock, likely due to increased investor interest and positive analyst ratings.
|
| 2024-07-01 | -0.22 % |
- Summary: The article compares BridgeBio Pharma and PepGen in terms of analyst recommendations, risk, profitability, earnings, institutional ownership, valuation, and dividends, indicating BridgeBio Pharma as having higher potential upside and favorable analysis due to various factors.
Reason for Leidos (LDOS) stock going down: The article does not directly mention the reason for Leidos (LDOS) stock going down. The focus of the article is on the comparison between BridgeBio Pharma and PepGen in the medical companies sector.
- Summary: Park Avenue Securities LLC reduced its position in Leidos Holdings, Inc. (LDOS) by 8.8% in the first quarter, leading to a -0.22% decrease in the company's stock, with other large investors also making changes to their positions, which possibly impacted the stock movement.
Reason for LDOS stock decrease: The reduction in Park Avenue Securities LLC's position in LDOS, along with other investors making changes to their positions, could have contributed to the stock decrease.
|
| 2024-06-27 | +0.54 % |
|
| 2024-06-26 | -1.28 % |
|
| 2024-06-25 | -0.18 % |
- The article reveals that 49 members of the 118th Congress have violated the federal insider trading and conflicts-of-interest law, with most violations related to failures in properly disclosing stock trades as required by the STOCK Act of 2012, causing Leidos (LDOS) stock to go down.
- The article provides an overview of undervalued stocks based on cash flows, focusing on companies like Alnylam Pharmaceuticals and New Oriental Education & Technology Group. Specifically, it mentions Leidos Holdings, Inc., which operates globally and was down by 0.18% as of last night. Leidos' stock likely experienced a decrease due to its slower revenue growth projections at 4.3% annually, combined with a high debt level and lower profit margins compared to the previous year, despite being awarded significant contracts, such as a US$738 million deal for IT and telecom support to the Air Force, which indicates potential undervaluation.
|
| 2024-06-13 | -0.3 % |
|
| 2024-06-10 | -0.09 % |
- The article discusses Tower Research Capital LLC TRC increasing its holdings in Leidos Holdings, Inc. (NYSE:LDOS) and various hedge funds modifying their holdings of the company, while mentioning recent ratings and target prices from different brokerages. Leidos stock went down by -0.09% recently, and this decline could be attributed to factors such as profit-taking, market sentiment, or overall market conditions affecting aerospace and defense industry stocks.
- The article discusses Seven Eight Capital LP acquiring a stake in Leidos Holdings, Inc. (NYSE:LDOS) and provides an update on other institutional investors increasing their stakes in LDOS. Despite this positive news, the stock of Leidos went down -0.09% last night, which can be influenced by market conditions, profit-taking activities, or investor sentiment.
- The article discusses how Schroder Investment Management Group reduced its holdings in Leidos Holdings, Inc. by 6.6%, leading to a slight decline in LDOS stock, which opened at $144.85 and was down by 0.09% last night. The decrease in stock value could be attributed to the reduction in holdings by institutional investors like Schroder Investment Management Group, Farmers & Merchants Trust Co of Chambersburg PA, Itau Unibanco Holding S.A., Lindbrook Capital LLC, Benjamin F. Edwards & Company Inc., and Tidemark LLC.
|
| 2024-06-06 | -0.98 % |
|
| 2024-06-04 | -0.69 % |
|
| 2024-05-31 | +1.22 % |
|
| 2024-05-30 | -0.3 % |
|
| 2024-05-29 | -1.26 % |
|
| 2024-05-28 | -2.36 % |
- The article compares mid-cap medical companies BridgeBio Pharma and Crinetics Pharmaceuticals, stating that Crinetics Pharmaceuticals has lower revenue but higher earnings than BridgeBio Pharma, and that Crinetics Pharmaceuticals is trading at a more affordable price-to-earnings ratio. The reason for Leidos (LDOS) stock going down is not directly addressed in the article, as the focus is on the comparison between BridgeBio Pharma and Crinetics Pharmaceuticals.
- The article discusses how PNC Financial Services Group Inc. increased its holdings in Leidos Holdings, Inc. (LDOS) by 7.5% in the fourth quarter, leading to the institutional investor owning 16,288 shares worth $1,763,000. The stock of Leidos (LDOS) went down by -2.36% last night due to multiple institutional investors buying and selling shares, as well as insider selling activities. Furthermore, the company recently announced strong earnings results, paying a quarterly dividend, and had received positive ratings from various analysts.
|
| 2024-05-24 | +0.92 % |
|
| 2024-05-22 | -0.24 % |
|
| 2024-05-21 | +0.56 % |
- The article discusses how Leidos Holdings, Inc. (NYSE:LDOS) stock was up by 0.56% and mentions that the increase could be attributed to various institutions modifying their holdings, positive analyst ratings, strong quarterly earnings, and the declaration of a quarterly dividend by the company.
- The article discusses Leidos Holdings, Inc. (NYSE: LDOS) stock, which was up by 0.56%. The increase in the stock price could be attributed to institutional investors adjusting their holdings, with Kentucky Retirement Systems reducing its shares by 2.4% and other firms like Victory Capital Management Inc., Wellington Management Group LLP, Massachusetts Financial Services Co. MA, Dimensional Fund Advisors LP, and FMR LLC, among others, modifying their positions in the fourth quarter. The company also recently posted positive quarterly earnings results and has received optimistic target price adjustments from research firms, indicating strong growth potential.
|
